iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

Data ReadoutpositiveGraftAssure AssayPositive

AI Analysis

Summary

iMDx announced publication of data in a Lancet Group journal demonstrating how its GraftAssure Assay guides the use of a kidney-graft-saving drug. The publication highlights the clinical utility of the diagnostic assay in transplant management.

Outcome Details

Publication in Lancet Group journal demonstrating GraftAssure Assay guides use of kidney-graft-saving drug

Importance:6/10

Sentiment:

0.60

kidney transplantdiagnostic assaypublicationgraft management

Related Companies

$IMDX

Read the original article

Published by yahoo_finance on July 23, 2026 12:00 PM

Read Original